Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sotatercept by Merck for Pulmonary Hypertension: Likelihood of Approval
Sotatercept is under clinical development by Merck and currently in Phase II for Pulmonary Hypertension. According to GlobalData, Phase II...